Cellular Longevity

Archival Status

The Cellular Longevity protocol combines Epitalon, MOTS-c, and Thymosin Alpha-1 — three distinct research compounds targeting the three primary molecular hallmarks of aging: telomere attrition (Epitalon), mitochondrial dysfunction (MOTS-c), and immune senescence (Thymosin Alpha-1). Epitalon (Epithalon) is a synthetic tetrapeptide based on a natural polypeptide extracted from the bovine pineal gland, originally developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Its primary mechanism involves activation of telomerase — the enzyme responsible for maintaining telomere length. Telomere attrition is one of the nine hallmarks of aging identified by Lopez-Otin et al. (2013). Research in multiple model organisms has shown Epitalon extends telomere length, reduces DNA damage markers, and correlates with increased lifespan in some animal studies. It also modulates melatonin secretion from the pineal gland, supporting circadian rhythm integrity — a key factor in healthy aging. MOTS-c is a microprotein encoded within the mitochondrial 12S rRNA gene, discovered in 2015. It operates as a mitochondrial signaling peptide that regulates glucose and lipid metabolism, activates AMPK (AMP-activated protein kinase), and promotes nuclear stress response pathways. Research shows MOTS-c supplementation improves insulin sensitivity, reverses age-related metabolic decline in animal models, and protects against high-fat diet-induced obesity. Crucially, circulating MOTS-c levels decline with age in humans, making exogenous supplementation a direct intervention against age-associated mitochondrial dysfunction. Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue and now produced synthetically. Its primary mechanism is immunomodulation — specifically, restoration of the adaptive immune response that deteriorates with age (thymic involution). Approved in multiple countries for hepatitis B, hepatitis C, and as an adjuvant in cancer immunotherapy, Thymosin Alpha-1 stimulates T-cell maturation, NK cell activity, and dendritic cell function. Together, these three compounds form a comprehensive longevity protocol addressing telomeres, mitochondria, and immunity — the three axes most consistently implicated in human aging research.